J Liver Cancer.  2015 Mar;15(1):36-40. 10.0000/jlc.2015.15.1.36.

Hemangioma Diagnosed by Gadoxetate Disodium-Enhanced MRI in a Patient with Chronic Hepatitis C

• Mo JW
• Ryu SH
• Park DW
• Yoon WJ
• Kim JN
• Moon JS
• Shim JC

• KMID: 2154072
• DOI: http://doi.org/10.0000/jlc.2015.15.1.36

Abstract

A hemangioma is the most common benign hepatic tumor. Many hepatic hemangioma tend to be found incidentally, but should be differentiated from malignant tumors, especially in patients with a high risk for malignancy. We presented a 52-year-old woman who diagnosed as hepatic hemangioma. The patient was a chronic alcohol abuser and diagnosed as a hepatic C virus carrier for the first time. Contrast enhanced abdominal computed tomography (CT) revealed a 4cm sized hepatic mass involving both segment 5 and 6. Abdominal CT finding suggested hepatic hemangioma, but could not rule out the malignancy. Because the patient had risk factors for hepatocellular carcinoma, abdominal ultrasonography (US) was performed for further evaluation. But abdominal US also showed atypical finding. For the confirmative diagnosis, dynamic magnetic resonance imaging using gadoxetate disodium (primovist(R), Bayer HealthCare, Berlin, Germany) which is the innovative liver cell-specific contrast medium was done, and the patient was diagnosed as hepatic hemangioma.

Keyword

Hepatitis C; Hemangioma; Gadoxetate disodium; Magnetic resonance imaging

MeSH Terms

Berlin
Carcinoma, Hepatocellular
Delivery of Health Care
Diagnosis
Female
Hemangioma*
Hepatitis C
Hepatitis C, Chronic*
Hepatitis, Chronic*
Humans
Liver
Magnetic Resonance Imaging*
Middle Aged
Risk Factors
Tomography, X-Ray Computed
Ultrasonography